Rtw Investments as of June 30, 2020
Portfolio Holdings for Rtw Investments
Rtw Investments holds 77 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 9.9 | $352M | 17M | 20.93 | |
| Alnylam Pharmaceuticals (ALNY) | 7.0 | $249M | 1.7M | 148.11 | |
| Ptc Therapeutics I (PTCT) | 5.7 | $201M | 4.0M | 50.74 | |
| Dicerna Pharmaceuticals | 5.1 | $182M | 7.2M | 25.40 | |
| Adverum Biotechnologies | 4.0 | $142M | 6.8M | 20.88 | |
| Immunovant (IMVT) | 3.9 | $139M | 5.7M | 24.35 | |
| Axsome Therapeutics (AXSM) | 3.8 | $136M | 1.7M | 82.28 | |
| Mirati Therapeutics | 3.5 | $124M | 1.1M | 114.17 | |
| Avidity Biosciences Ord (RNA) | 2.9 | $104M | 4.0M | 26.00 | |
| Myokardia | 2.5 | $91M | 937k | 96.62 | |
| Masimo Corporation (MASI) | 2.5 | $89M | 389k | 227.99 | |
| Stoke Therapeutics (STOK) | 2.4 | $85M | 3.5M | 23.83 | |
| Baxter International (BAX) | 2.3 | $84M | 969k | 86.10 | |
| Cerner Corporation | 2.3 | $81M | 1.2M | 68.55 | |
| Natera (NTRA) | 2.1 | $76M | 1.5M | 49.86 | |
| Translate Bio | 1.9 | $67M | 3.7M | 17.92 | |
| Relmada Therapeutics (RLMD) | 1.9 | $66M | 1.5M | 44.75 | |
| Axonics Modulation Technolog (AXNX) | 1.9 | $66M | 1.9M | 35.11 | |
| Homology Medicines | 1.9 | $66M | 4.4M | 15.19 | |
| Bellus Health Com New | 1.7 | $62M | 6.0M | 10.31 | |
| Protagonist Therapeutics (PTGX) | 1.7 | $60M | 3.4M | 17.66 | |
| Tandem Diabetes Care Com New (TNDM) | 1.7 | $59M | 599k | 98.92 | |
| 10x Genomics Cl A Com (TXG) | 1.6 | $57M | 636k | 89.31 | |
| Oyster Point Pharma | 1.6 | $55M | 1.9M | 28.88 | |
| Vericel (VCEL) | 1.5 | $53M | 3.9M | 13.82 | |
| Agenus Com New | 1.4 | $51M | 13M | 3.93 | |
| Frequency Therapeutics | 1.4 | $50M | 2.2M | 23.25 | |
| Establishment Labs Holdings Ord (ESTA) | 1.2 | $43M | 2.3M | 18.68 | |
| Avadel Pharmaceuticals Sponsored Adr | 1.2 | $43M | 5.3M | 8.08 | |
| Dermtech Ord ord (DMTKQ) | 1.1 | $38M | 2.9M | 13.23 | |
| Macrogenics (MGNX) | 1.0 | $35M | 1.2M | 27.92 | |
| Celldex Therapeutics Com New (CLDX) | 1.0 | $34M | 2.6M | 13.00 | |
| Iveric Bio | 0.9 | $34M | 6.6M | 5.10 | |
| Castle Biosciences (CSTL) | 0.9 | $30M | 804k | 37.69 | |
| ProQR Thrapeutics N V Shs Euro (PRQR) | 0.8 | $30M | 4.9M | 6.08 | |
| Nanostring Technologies (NSTGQ) | 0.8 | $28M | 947k | 29.35 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.7 | $26M | 2.6M | 10.01 | |
| WAVE Life Sciences SHS (WVE) | 0.7 | $25M | 2.4M | 10.41 | |
| Odonate Therapeutics Ord | 0.6 | $20M | 481k | 42.34 | |
| STAAR Surgical Com Par $0.01 (STAA) | 0.5 | $19M | 309k | 61.54 | |
| Apyx Medical Corporation (APYX) | 0.5 | $19M | 3.4M | 5.55 | |
| OraSure Technologies (OSUR) | 0.5 | $18M | 1.5M | 11.63 | |
| Johnson & Johnson (JNJ) | 0.5 | $18M | 127k | 140.63 | |
| Tela Bio (TELA) | 0.5 | $18M | 1.4M | 12.96 | |
| Milestone Pharmaceuticals (MIST) | 0.5 | $16M | 4.3M | 3.78 | |
| Exagen (XGN) | 0.4 | $16M | 1.3M | 12.41 | |
| MiMedx (MDXG) | 0.4 | $15M | 2.7M | 5.40 | |
| Neogenomics Com New (NEO) | 0.4 | $14M | 445k | 30.98 | |
| GenMark Diagnostics | 0.4 | $14M | 935k | 14.71 | |
| Cytomx Therapeutics (CTMX) | 0.4 | $13M | 1.5M | 8.33 | |
| Arbutus Biopharma (ABUS) | 0.4 | $13M | 6.9M | 1.82 | |
| Amyris Com New | 0.3 | $12M | 3.1M | 4.00 | |
| Regenxbio Inc equity us cm (RGNX) | 0.3 | $12M | 316k | 36.83 | |
| La Jolla Pharmaceutical Com Par $.0001 2 | 0.3 | $10M | 2.4M | 4.26 | |
| Transmedics Group (TMDX) | 0.3 | $9.0M | 503k | 17.92 | |
| Itamar Med Sponsored Ads | 0.2 | $8.5M | 457k | 18.60 | |
| Clearside Biomedical (CLSD) | 0.2 | $7.4M | 3.9M | 1.88 | |
| argenx SE Sponsored Adr (ARGX) | 0.2 | $7.2M | 32k | 225.25 | |
| Uniqure NV SHS (QURE) | 0.2 | $7.1M | 157k | 45.06 | |
| Inmode SHS (INMD) | 0.2 | $7.1M | 250k | 28.32 | |
| Repare Therapeutics Ord (RPTX) | 0.2 | $7.0M | 225k | 31.02 | |
| Brainsway Sponsored Ads (BWAY) | 0.2 | $6.6M | 1.1M | 5.92 | |
| Arvinas Ord (ARVN) | 0.2 | $5.8M | 174k | 33.54 | |
| ARYA Sciences Acquistion Unit 06/09/2027 | 0.2 | $5.8M | 500k | 11.60 | |
| Lifesci Acquisition Corp Unit 03/31/2025 | 0.2 | $5.5M | 500k | 11.00 | |
| Chardan Healthcr Acqstn 2 Unit 99/99/9999 | 0.1 | $3.7M | 350k | 10.50 | |
| Chardan Healthcare Acqu- Ord | 0.1 | $3.3M | 600k | 5.52 | |
| Personalis Ord (PSNL) | 0.1 | $3.3M | 255k | 12.97 | |
| Profound Med Corp Com New (PROF) | 0.1 | $3.0M | 174k | 16.94 | |
| Progenity | 0.1 | $2.5M | 275k | 9.00 | |
| Inari Medical Ord | 0.1 | $2.2M | 45k | 48.44 | |
| Fulgent Genetics (FLGT) | 0.0 | $1.2M | 75k | 16.00 | |
| Motus Gi Hldgs Incorporated | 0.0 | $1.0M | 776k | 1.32 | |
| Twist Bioscience Corp (TWST) | 0.0 | $837k | 19k | 45.31 | |
| Burning Rock Biotech Sponsored Ads | 0.0 | $810k | 30k | 27.00 | |
| Viewray (VRAYQ) | 0.0 | $336k | 150k | 2.24 | |
| BiomX *w Exp 10/16/202 (PHGEW) | 0.0 | $287k | 600k | 0.48 |